.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Julphar
Fuji
Dow
Teva
Express Scripts
Queensland Health
Farmers Insurance
Covington
Citi

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,776,433

« Back to Dashboard

Summary for Patent: 5,776,433

Title: Flunisolide aerosol formulations
Abstract:Pharmaceutical aerosol formulations substantially free of chlorofluorocarbons and comprising a therapeutically effective amount of flunisolide in solution with ethanol and a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane and a mixture thereof are used for the treatment of bronchial asthma. The formulation may be delivered by a metered dose inhaler with a canister that is inert to flunisolide.
Inventor(s): Tzou; Tsi-Zong (Lake Elmo, MN), Schultz; Robert K. (Edina, MN), Ross; Danna L. (Pine Springs, MN)
Assignee: Minnesota Mining and Manufacturing Company (St. Paul, MN)
Application Number:08/456,029
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use; Delivery;

No matches for this query

International Patent Family for Patent: 5,776,433

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia1098695► Subscribe
Australia680967► Subscribe
Canada2178473► Subscribe
Germany69424181► Subscribe
Denmark0735884► Subscribe
European Patent Office0735884► Subscribe
Spain2145254► Subscribe
JapanH09506896► Subscribe
Norway313123► Subscribe
Norway962585► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
US Department of Justice
Healthtrust
Moodys
Daiichi Sankyo
Mallinckrodt
Cantor Fitzgerald
Covington
Deloitte
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot